8 September 2021
Impact Healthcare REIT plc
("Impact" or the "Company" or, together with its subsidiaries, the "Group")
PDMR Notification
The Company announces that Chris Santer, Non-Executive Director of the Company and a person discharging managerial responsibilities in the Company ("PDMR"), on 8 September 2021, has acquired 12,567 ordinary shares at a price of 118.60 pence per share.
In total Chris Santer will be interested in 12,567 Ordinary Shares, representing approximately 0.0036% per cent of the Company's issued Ordinary Share capital.
PDMR Notification Form:
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details:
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. |
Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA") |
|||||
a) |
Name |
Christopher John Santer |
||||
2. |
Reason for the Notification |
|||||
a) |
Position/status |
PDMR |
||||
b) |
Initial notification/amendment |
Initial notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Impact Healthcare REIT PLC |
||||
b) |
LEI |
213800AX3FHPMJL4IJ53 |
||||
4. |
Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the Financial instrument, type of instrument |
Ordinary Shares of 1 pence each |
||||
Identification code |
GB00BYXVMJ03 |
|||||
b) |
Nature of the Transaction |
Acquisition of Shares |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information |
12,567 ordinary shares in aggregate |
||||
e) |
Date of the transaction |
8 September 2021 |
||||
f) |
Place of the transaction |
London Stock Exchange |
ENDS
JTC (UK) Limited - Company Secretary Christopher Gibbons |
+44 (0) 203 846 9774 |